Retinal vascular rescue of oxygen-induced retinopathy in mice by norrin

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 1, 2013, Pages 222-229

  Tokunaga, Clayton C ^a   Chen, Yi Hao ^a,b   Dailey, Wendelin ^a   Cheng, Mei ^a   Drenser, Kimberly A ^a  

^a OAKLAND UNIVERSITY   (United States)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DICKKOPF 1 PROTEIN; NORRIN; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; HISTOLOGY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RETINA BLOOD VESSEL; RETINA NEOVASCULARIZATION; RETINOPATHY; VASCULARIZATION; WNT SIGNALING PATHWAY;

ANIMALS; ANIMALS, NEWBORN; BODY WEIGHT; DISEASE MODELS, ANIMAL; EYE PROTEINS; HUMANS; INFANT, NEWBORN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRAVITREAL INJECTIONS; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; NERVE TISSUE PROTEINS; OXYGEN; RETINA; RETINAL NEOVASCULARIZATION; RETINOPATHY OF PREMATURITY; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 84874694773     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-10127     Document Type: Article

References (33)

1. Schuback DE, Chen ZY, Craig IW, Breakefield XO, Sims KB. Mutations in the Norrie disease gene. Hum Mutat. 1995;5: 285-292.
2. Meindl A, Berger W, Meitinger T, et al. Norrie disease is caused by mutations in an extracellular protein resembling C-terminal globular domain of mucins. Nat Genet. 1992;2:139-143.
3. Berger W, van de Pol D, Warburg M, et al. Mutations in the candidate gene for Norrie disease. Hum Mol Genet. 1992;1: 461-465.
4. Shastry BS, Hejtmancik JF, Plager DA, Hartzer MK, Trese MT. Linkage and candidate gene analysis of X-linked familial exudative vitreoretinopathy. Genomics. 1995;27:341-344.
5. Chen ZY, Battinelli EM, Fielder A, et al. A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy. Nat Genet. 1993;5:180-183.
6. Black GC, Perveen R, Bonshek R, et al. Coats' disease of the retina (unilateral retinal telangiectasis) caused by somatic mutation in the NDP gene: a role for norrin in retinal angiogenesis. Hum Mol Genet. 1999;8:2031-2035.
7. Talks SJ, Ebenezer N, Hykin P, et al. De novo mutations in the 50 regulatory region of the Norrie disease gene in retinopathy of prematurity. J Med Genet. 2001;38:E46.
8. Hutcheson KA, Paluru PC, Bernstein SL, et al. Norrie disease gene sequence variants in an ethnically diverse population with retinopathy of prematurity. Mol Vis. 2005;11:501-508.
9. Hiraoka M, Berinstein DM, Trese MT, Shastry BS. Insertion and deletion mutations in the dinucleotide repeat region of the Norrie disease gene in patients with advanced retinopathy of prematurity. J Hum Genet. 2001;46:178-181.
10. Xu Q, Wang Y, Dabdoub A, et al. Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a highaffinity ligand-receptor pair. Cell. 2004;116:883-895.
11. Descamps B, Sewduth R, Ferreira Tojais N, et al. Frizzled 4 regulates arterial network organization through noncanonical Wnt/planar cell polarity signaling. Circ Res. 2012;110:47-58.
12. Yao R, Natsume Y, Noda T. MAGI-3 is involved in the regulation of the JNK signaling pathway as a scaffold protein for frizzled and Ltap. Oncogene. 2004;23:6023-6030.
13. Robitaille J, MacDonald ML, Kaykas A, et al. Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy. Nat Genet. 2002;32:326-330.
14. Junge H, Yang S, Burton J, et al. TSPAN12 regulates retinal vascular development by promoting norrin, but not Wntinduced FZD4/b-catenin signaling. Cell. 2009;139:299-311.
15. Berger W. Molecular dissection of Norrie disease. Acta Anat (Basel). 1998;162:95-100.
16. Black G, Redmond RM. The molecular biology of Norrie's disease. Eye. 1994;8:491-496.
17. McDonald NQ, Hendrickson WA. A structural superfamily of growth factors containing a cystine knot motif. Cell. 1993;73: 421-424.
18. Ohlmann A, Seitz R, Braunger B, Seitz D, Bosl MR, Tamm ER. Norrin promotes vascular regrowth after oxygen-induced retinal vessel loss and suppresses retinopathy in mice. J Neurosci. 2010;30:183-193.
19. Smith LE, Wesolowski E, McLellan A, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994;35: 101-111.
20. Stahl A, Chen J, Sapieha P, et al. Postnatal weight gain modifies severity and functional outcome of oxygen-induced proliferative retinopathy. Am J Pathol. 2010;177:2715-2723.
21. Connor KM, Krah NM, Dennison RJ, et al. Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc. 2009;4:1565-1573.
22. Stahl A, Connor KM, Sapieha P, et al. Computer-aided quantification of retinal neovascularization. Angiogenesis. 2009;12:297-301.
23. Zeng G. Orientation of endothelial cell division is regulated by VEGF signaling during blood vessel formation. Blood. 2007; 109:1345-1352.
24. Dejana E. The role of Wnt signaling in physiological and pathological angiogenesis. Circ Res. 2010;107:943-952.
25. Chen J, Stahl A, Krah NM, et al. Wnt signaling mediates pathological vascular growth in proliferative retinopathy. Circulation. 2011;124:1871-1881.
26. Rao TP, K̈thl M. An updated overview on Wnt signaling pathways. A prelude for more. Circ Res. 2010;106:1798-1806.
27. Mikels A, Nusse R. Purified Wnt5a protein activates or inhibits b-Catenin-TCF signaling depending on receptor context. PLoS Biol. 2006;4:570-582.
28. Tamm E, Ohlmann A, inventors; Universitat Regensburg, assignee. Norrin in the treatment of diseases associated with an increased TGF-beta activity. European patent EP20090798920. September 28, 2011.
29. Sonmez K, Drenser K, Capone A, Trese M. Vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity. Ophthalmology. 2008;115:1065-1070.
30. Robitaille J, Zheng B, Wallace K, et al. The role of Frizzled-4 mutations in familial exudative vitreoretinopathy and Coats disease. Br J Ophthalmol. 2011;95:574-579.
31. Chen Y, Hu Y, Zhou T, et al. Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models. Am J Pathol. 2009;175:2676-2685.
32. Wu WC, Drenser K, Trese M, Capone A Jr, Dailey W. Retinal phenotype-genotype correlation of pediatric patients expressing mutations in the Norrie disease gene. Arch Ophthalmol. 2007;125:225-230.
33. Chen J, Stahl A, Krah NM, et al. Retinal expression of Wntpathway mediated genes in low-density lipoprotein receptorrelated protein 5 (Lrp5) knockout mice. PLoS One. 2012;7: e0030203.